A young man with severe asthma used to be able to get his inhaler for cheap, but after UnitedHealthcare's drug arm jacked up the price, he had to go without — and it ultimately killed him ...

“Yesterday there was a kid who came up on the street and said, ‘your music helped me out of a dark place,’” says the Inhaler frontman, piling into none-less-rock’n’roll mineral waters ...

Before you toss your inhaler, read the manufacturer’s instructions. They may provide information on properly disposing of the device. If the instructions aren’t clear, contact your pharmacist ...

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the immediate impact Spravato has had on patients with treatment-resistant ...

An inhaler is a handheld device that delivers a puff or spray of these medicines straight into your lungs through a mouthpiece. Inhalers work faster than pills, which have to travel through your ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the approval of Spravato for treatment-resistant depression. PE: How does ...

Johnson & Johnson's Spravato has been approved to treat a major depressive disorder in adults who have had an inadequate response to at least two oral antidepressants, the FDA announced Tuesday.

"SPRAVATO ® is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily oral ...

The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more. Joe Biden Signs With CAA I made coffee using 4 ...

Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients per week. According to Parkside, these patients are seen at least twice a week for the ...

Novartis and Qualcomm are to develop a 'smart' COPD inhaler to allow patients to digitally ... offer a 'completely integrated' and connected device. Novartis will work with technology giant ...